Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep259 | Calcium & Vitamin D metabolism | ECE2017

Vitamin D prescribing bias in liver transplant referrals

Gan KJ , O'Sullivan Niamh , Hanley Bernadette , Armstrong Paul , Kilbane Mark , Houlihan Diarmaid , Crowley Rachel

Vitamin D (VD) deficiency (25 OHD < 50 nmol/l) is common is chronic liver disease at 64%–92% regardless of aetiology. The only guidelines for routine VD supplementation are for cholestatic (C) liver disease; a population considered being at high risk of low bone mineral density (BMD). BMD decreases further following orthotopic liver transplant (OLT). To assess VD intake in an at risk population, retrospective analysis of intake was performed in OLT patients with C liv...

ea0052nets11 | Speaker Abstracts | UKINETS2017

Debate: There is a role in resection of NET hepatic metastases - surgical dilemma

Armstrong Tom

Tom Armstrong will present evidence to support the role of surgical resection NET liver in the case based discussion detailed above....

ea0028oc4.7 | Steroid | SFEBES2012

Glucocorticoids increase subcutaneous adipose tissue insulin sensitivity in vivo: a randomised double-blind, placebo controlled, cross over study

Hazlehurst Jonathan , Armstrong Matthew , Borrows Sarah , Gathercole Laura , Stewart Paul , Tomlinson Jeremy

Glucocorticoid (GC) excess, Cushing’s syndrome, is characterized by central obesity, proximal myopathy, insulin resistance and potentially type 2 diabetes mellitus. Current dogma dictates that GCs cause insulin resistance across all tissues. We have previously demonstrated that GCs cause insulin sensitization of human adipose tissue in vitro, whilst inducing insulin resistance in human skeletal muscle. No prior study has evaluated whether these observations transla...

ea0028p48 | Clinical practice/governance and case reports | SFEBES2012

A comparative quality assessment of evidence-based clinical guidelines in Endocrinology

Hazlehurst Jonathan , Armstrong Matthew , Sherlock Mark , O'Reilly Mick , Rowe Ian , Franklyn Jayne , Stewart Paul , Tomlinson Jeremy

Evidence-based clinical guidelines in Endocrinology attempt to improve and standardise patient care. There has been an expansion in guideline production although some of the heterogeneous methods used to assess the underlying evidence base may limit interpretation and implementation. Current and archived guidelines from The American Association of Clinical Endocrinologists (AACE), The Endocrine Society (ES), The American Thyroid Association, The British Thyroid Association and...

ea0034s1.1 | GNRH biology ‐ from pulses to longevity (Supported by <emphasis role="italic">Journal of Molecular Endocrinology</emphasis>) | SFEBES2014

Systems approaches to understanding GnRH signalling

Perrett Rebecca , Voliotis Margaritis , Armstrong Stephen , Pope George , Tsaneva-Atanasova Krasimira , McArdle Craig

GnRH acts via Gq/11-coupled GPCRs on gonadotropes to control synthesis and secretion of LH and FSH. We use mathematical and statistical approaches as well as automated cell imaging to explore this system. In cells expressing ERK2–GFP and GnRH receptors, GnRH pulses cause rapid and transient nuclear translocation of ERK2–GFP, providing a live-cell readout for ERK activation1. A mathematical model trained against this data predicted greater sensitivity to re...

ea0094ns2.1 | Thyroid Cancer | SFEBES2023

Nurse led - Holistic care in Thyroid cancer

Armstrong Nicola

The management of patient care is to ensure that individuals are provided with appropriate support and representation during their cancer journey, from the point of diagnosis, throughout treatment and into survivorship. The Clinical Nurse Specialist (CNS) role has become pivotal in many specialities, providing aspects of care such as meeting information needs, holistic nurse led follow up, managing care and providing psychological and social interventions, including referral t...

ea0080OC3 | Oral Communications | UKINETS2021

An update on the effects of debulking surgery and liver directed intra-arterial therapies on quality of life in patients with metastatic neuroendocrine tumours

Woods Eleanor , Sinclair Adam , Jarvis Emma , Ramsey Emma , Tanno Lulu , Naheed Salma , Armstrong Thomas , Takhar Arjun , Knight John , Stedman Brian , Modi Sachin , Bryant Timothy , Breen David , Nolan Luke , Al-Mrayat Ma'en , Pearce Neil , Cave Judith

Background: Neuroendocrine tumours (NETs) arise from neuroendocrine cells, they are commonly found in the pancreas, small bowel and lung. They are a heterogeneous group of tumours capable of secreting a variety of hormones, therefore the spectrum of symptoms is broad. Treatment options for metastatic NETs include cytoreductive surgery, or interventional radiology procedures such as transarterial embolization (TAE). Aims: Previous studies have shown that ...

ea0081ep532 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

A case of idiopathic postprandial syndrome in a middle-aged nigerian woman

Jesuyajolu Damilola , Mohammed Abdulhafeez , Okeke Charles , Nicholas Armstrong

Introduction: Not much has been reported about Idiopathic Postprandial syndrome, especially in Africa. Many cases are often wrongly diagnosed as reactive hypoglycemia. Idiopathic postprandial syndrome refers to signs and symptoms of hypoglycemia in the absence of low blood sugar occurring after meals and is of unknown cause. Clinical case: We report a case of Idiopathic Postprandial Syndrome in a 44-year old woman living in Nigeria. We present a 44-year-...

ea0038fp9 | (1) | SFEBES2015

How well can we measure oestradiol?

Owen Laura , Monaghan Phillip , Armstrong Annie , Keevil Brian

Traditionally, oestradiol measurement is performed by immunoassay. The sensitivity of these assays is not sufficiently sensitive for certain patient groups such as males, post-menopausal females and children. There is also a potential for interference from structurally related compounds or heterophilic antibodies. LC–MS/MS is an attractive alternative as it has increased sensitivity and specificity.We reviewed the requests for LC–MS/MS analysis...

ea0037ep1094 | Endocrine tumours | ECE2015

Plasma chromogranin A and chromogranin B concentrations in untreated patients with mid gut carcinoid and their biochemical response to octreotide

Armstrong Lee , Rea Teresa , Johnston Brian , McCance David

We measured chromogranin A (CgA) and chromogranin B (CgB) in 36 patients, recently confirmed to have a midgut carcinoid tumour (MGC), prior to the commencement of octreotide treatment. Blood samples were taken before and after a bolus injection of 50 μg octreotide. There were 21 males, 15 females, age range 28–76 median 61 years.Basal CgA, expressed as times the upper limit of normal (ULN) ranged from 333.3 to 0.5 ULN. Basal CgB ranged from 33....